Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John A Morrow

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Current Opinion in Drug Discovery & Development|September 28, 2006
Recent advances in positive allosteric modulators of the AMPA receptorJohn A Morrow, John K F Maclean, Craig Jamieson
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 7, 2005
Comparison of alterations in c-fos and Egr-1 (zif268) expression throughout the rat brain following acute administration of different classes of antidepressant compoundsDavid A Slattery, John A Morrow, Alan L Hudson, et al.
Combinatorial Chemistry & High Throughput Screening|February 4, 2006
Development of a novel high-throughput assay for the investigation of GlyT-1b neurotransmitter transporter functionLynda Allan, J Lianne Leith, Marianthi Papakosta, et al.
Mini Reviews in Medicinal Chemistry|February 10, 2009
Antiglucocorticoids, neurogenesis and depressionCarlos P Fitzsimons, Lenneke W A van Hooijdonk, John A Morrow, et al.
Psychopharmacology|September 21, 2013
The relationship between glycine transporter 1 occupancy and the effects of the glycine transporter 1 inhibitor RG1678 or ORG25935 on object retrieval performance in scopolamine impaired rhesus monkeyDonnie Eddins, Terence G Hamill, Vanita Puri, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2010
Structure based evolution of a novel series of positive modulators of the AMPA receptorCraig Jamieson, John K F Maclean, Christopher I Brown, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 2010
A novel series of positive modulators of the AMPA receptor: structure-based lead optimizationCraig Jamieson, Robert A Campbell, Iain A Cumming, et al.
Elife|January 30, 2016
Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPasesMartin Steger, Francesca Tonelli, Genta Ito, et al.
Bioorganic & Medicinal Chemistry Letters|September 1, 2010
A novel series of positive modulators of the AMPA receptor: discovery and structure based hit-to-lead studiesCraig Jamieson, Stephanie Basten, Robert A Campbell, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 27, 2015
MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase InhibitionMatthew J Fell, Christian Mirescu, Kallol Basu, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Opinion in Drug Discovery & Development|September 28, 2006
Recent advances in positive allosteric modulators of the AMPA receptorJohn A Morrow, John K F Maclean, Craig Jamieson
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 7, 2005
Comparison of alterations in c-fos and Egr-1 (zif268) expression throughout the rat brain following acute administration of different classes of antidepressant compoundsDavid A Slattery, John A Morrow, Alan L Hudson, et al.
Combinatorial Chemistry & High Throughput Screening|February 4, 2006
Development of a novel high-throughput assay for the investigation of GlyT-1b neurotransmitter transporter functionLynda Allan, J Lianne Leith, Marianthi Papakosta, et al.
Mini Reviews in Medicinal Chemistry|February 10, 2009
Antiglucocorticoids, neurogenesis and depressionCarlos P Fitzsimons, Lenneke W A van Hooijdonk, John A Morrow, et al.
Psychopharmacology|September 21, 2013
The relationship between glycine transporter 1 occupancy and the effects of the glycine transporter 1 inhibitor RG1678 or ORG25935 on object retrieval performance in scopolamine impaired rhesus monkeyDonnie Eddins, Terence G Hamill, Vanita Puri, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2010
Structure based evolution of a novel series of positive modulators of the AMPA receptorCraig Jamieson, John K F Maclean, Christopher I Brown, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 2010
A novel series of positive modulators of the AMPA receptor: structure-based lead optimizationCraig Jamieson, Robert A Campbell, Iain A Cumming, et al.
Elife|January 30, 2016
Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPasesMartin Steger, Francesca Tonelli, Genta Ito, et al.
Bioorganic & Medicinal Chemistry Letters|September 1, 2010
A novel series of positive modulators of the AMPA receptor: discovery and structure based hit-to-lead studiesCraig Jamieson, Stephanie Basten, Robert A Campbell, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 27, 2015
MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase InhibitionMatthew J Fell, Christian Mirescu, Kallol Basu, et al.
Pageof 2